Bio-Techne and Myriad Genetics are identified as key players in the biomarkers industry, while the American Cancer Society provides prostate cancer prevalence statistics.

The entities involved

• Bio-Techne →

  company

  • Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.Sun 13:32
  • Trump pledged to unleash American oil and gas, involving MBX Biosciences, Inc.Sun 05:01
• Myriad Genetics →

  American biotechnology company

  • MarketBeat is reporting on analyst recommendations and consensus target prices for small-cap healthcare companies Myriad Genetics and Applied DNA Sciences.Fri 11:44
• American Cancer Society →

  health organization seeking to cure and treat cancer

  • The American Cancer Society is advocating for pediatric cancer research funding in partnership with Rutland County.Fri 06:24
  • The American Cancer Society and National Comprehensive Cancer Network published findings in a journal regarding cancer in the United States.Thu 22:21